18,077 followers
Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer: Introduction, Small cell lung cancer (SCLC) is a rapidly progressing aggressive malignancy. Durvalumab in… #oncology https://t.co/MXw7O